FDA Inspection 878016 — Zydus Pharmaceuticals (USA) Inc
The FDA completed an inspection of Zydus Pharmaceuticals (USA) Inc on May 15, 2014 in Pennington, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 15, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Pennington, NJ (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)